Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …

Background Combined oral contraceptive (COC) use has been associated with venous
thrombosis (VT)(ie, deep venous thrombosis and pulmonary embolism). The VT risk has …

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …

Background Although several studies have assessed the risk of venous thromboembolism
with newer hormonal contraception, few have examined thrombotic stroke and myocardial …

Objective To provide a comprehensive overview of the risk of venous thrombosis in women
using different combined oral contraceptives. Design Systematic review and network meta …

Objective To assess the risk of venous thromboembolism from use of combined oral
contraceptives according to progestogen type and oestrogen dose. Design National …

BACKGROUND Hirsutism, defined by the presence of excessive terminal hair in androgen-
sensitive areas of the female body, is one of the most common disorders in women during …

The safety of progestogens as a class has come under increased scrutiny after the
publication of data from the Women's Health Initiative trial, particularly with respect to breast …

Objective To investigate the association between use of combined oral contraceptives and
risk of venous thromboembolism, taking the type of progestogen into account. Design Two …

Objective To assess the risk of pulmonary embolism, ischaemic stroke, and myocardial
infarction associated with combined oral contraceptives according to dose of oestrogen …